Researchers sought to evaluate the impact of risankizumab vs placebo on health care-related quality of life and other patient-reported outcomes in patients with psoriatic arthritis.
Researchers assessed the risk for key safety outcome infections during treatment with secukinumab and tumor necrosis factor inhibitors for axial spondyloarthritis and psoriatic arthritis.
Researchers sought to determine whether previous use of biologic DMARDs impacted the overall performance of 17DD-YF vaccination in patients with spondyloarthritis.
Researchers analyzed a large dataset of patients with SpA to determine the prevalence, clinical features, and sex-specific differences of concomitant fibromyalgia and enthesitis.
Researchers assessed the validity and reliability of the Physician’s Global Assessment of Fingernail Psoriasis (PGA-F) in the treatment of patients with psoriatic arthritis.